2023
One‐year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J‐PCI OUTCOME registry
Numasawa Y, Sawano M, Ishii H, Kohsaka S, Kikuta Y, Matoba T, Amano T, Kozuma K, Investigators T. One‐year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J‐PCI OUTCOME registry. Catheterization And Cardiovascular Interventions 2023, 102: 1229-1237. PMID: 37943854, DOI: 10.1002/ccd.30895.Peer-Reviewed Original ResearchConceptsMajor adverse cardiovascular eventsDirectional coronary atherectomyPercutaneous coronary interventionStable coronary artery diseaseOne-year outcomesCoronary artery diseaseMajor bleedingCoronary interventionUnstable anginaArtery diseaseDCA groupContemporary real-world practiceDrug-coated balloon angioplastyOne-year clinical outcomesJapanese nationwide registryNonfatal major bleedingAdverse cardiovascular eventsCardiovascular deathCardiovascular eventsCause mortalityMidterm outcomesBaseline characteristicsCardiovascular mortalityCoronary atherectomyNationwide registry
2022
Overview of in‐hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy
Numasawa Y, Inohara T, Ishii H, Yamaji K, Kohsaka S, Sawano M, Amano T, Nakamura M, Ikari Y, Investigators J. Overview of in‐hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy. Catheterization And Cardiovascular Interventions 2022, 100: 51-58. PMID: 35592940, DOI: 10.1002/ccd.30233.Peer-Reviewed Original ResearchConceptsStable coronary artery diseaseCoronary artery diseaseHospital outcomesUnstable anginaArtery diseaseDCA groupContemporary real-world practiceDrug-coated balloon angioplastyPercutaneous coronary intervention registryHospital adverse outcomesLeft main trunkChronic kidney diseaseDirectional coronary atherectomyPercutaneous coronary interventionCoronary Intervention RegistryLow complication rateTotal contrast volumePreferred treatment strategyPeriprocedural complicationsArtery lesionsBaseline characteristicsComplication rateCoronary atherectomyCoronary interventionIntervention Registry
2020
Association of the Hemoglobin to Serum Creatinine Ratio with In-Hospital Adverse Outcomes after Percutaneous Coronary Intervention among Non-Dialysis Patients: Insights from a Japanese Nationwide Registry (J-PCI Registry)
Numasawa Y, Inohara T, Ishii H, Yamaji K, Kohsaka S, Sawano M, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M, Ikari Y. Association of the Hemoglobin to Serum Creatinine Ratio with In-Hospital Adverse Outcomes after Percutaneous Coronary Intervention among Non-Dialysis Patients: Insights from a Japanese Nationwide Registry (J-PCI Registry). Journal Of Clinical Medicine 2020, 9: 3612. PMID: 33182592, PMCID: PMC7696709, DOI: 10.3390/jcm9113612.Peer-Reviewed Original ResearchPercutaneous coronary interventionNon-dialysis patientsHospital adverse outcomesJapanese nationwide registryAdverse outcomesHospital mortalityCoronary interventionNationwide registryCr ratioComplex coronary artery diseaseIn-Hospital Adverse OutcomesHospital clinical outcomesSpline curve analysisHigher creatinine levelsCoronary artery diseaseSerum creatinine ratioBaseline hemoglobinMore comorbiditiesJapanese medical institutionsBaseline characteristicsCreatinine levelsRenal functionArtery diseaseCreatinine ratioLower hemoglobinApplicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention
Niimi N, Sawano M, Ikemura N, Nagai T, Nakano S, Shoji S, Shiraishi Y, Ueda I, Numasawa Y, Suzuki M, Noma S, Fukuda K, Kohsaka S. Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention. Journal Of Clinical Medicine 2020, 9: 2889. PMID: 32906673, PMCID: PMC7564619, DOI: 10.3390/jcm9092889.Peer-Reviewed Original ResearchPercutaneous coronary interventionNon-eligible patientsComparative Health EffectivenessSevere ischemiaEligible patientsBaseline characteristicsCoronary interventionRCT patientsStable ischemic heart disease patientsHealth effectivenessMajor adverse cardiac eventsIschemic heart disease patientsRole of revascularizationAdverse cardiac eventsEarly invasive strategyInvasive Approaches (ISCHEMIA) trialHeart disease patientsInternational studiesSIHD patientsMulticenter registryPCI patientsCardiac eventsISCHEMIA trialDisease patientsBaseline cohortIschemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment
Shoji S, Sawano M, Sandhu A, Heidenreich P, Shiraishi Y, Ikemura N, Ueno K, Suzuki M, Numasawa Y, Fukuda K, Kohsaka S. Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment. JAMA Network Open 2020, 3: e202004. PMID: 32239221, PMCID: PMC7118520, DOI: 10.1001/jamanetworkopen.2020.2004.Peer-Reviewed Original ResearchMeSH KeywordsAcute Coronary SyndromeAgedAged, 80 and overAspirinBrain IschemiaCase-Control StudiesClopidogrelDeathDrug Therapy, CombinationFemaleHemorrhageHumansJapanMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPrasugrel HydrochlorideRegistriesRenal Insufficiency, ChronicRetrospective StudiesRisk AssessmentStrokeConceptsLow-dose prasugrelPercutaneous coronary interventionPrimary ischemic eventsAcute coronary syndromeBleeding eventsIschemic eventsCoronary syndromeST-segment elevation myocardial infarctionAcute Coronary Syndrome AssociatedPropensity score-matched analysisHigh-bleeding riskStandard-dose clopidogrelChronic kidney diseaseElevation myocardial infarctionPresent cohort studyShort-term outcomesEast Asian patientsReal-world outcomesPrasugrel treatmentClopidogrel administrationP2Y12 inhibitorsBaseline characteristicsClopidogrel treatmentCohort studyCoronary intervention